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Abstract
Background: Characteration of the newly identified duck enteritis virus UL55 gene product has not been reported
yet. Knowledge of the protein UL55 can provide useful insights about its function.
Results: The newly identified duck enteritis virus UL55 gene was about 561 bp, it was amplified and digested for
construction of a recombinant plasmid pET32a(+)/UL55 for expression in Escherichia coli. SDS-PAGE analysis
revealed the recombinant protein UL55(pUL55) was overexpressed in Escherichia coli BL21 host cells after
induction by 0.2 mM IPTG at 37°C for 4 h and aggregated as inclusion bodies. The denatured protein about 40
KDa named pUL55 was purified by washing five times, and used to immune rabbits for preparation of polyclonal
antibody. The prepared polyclonal antibody against pUL55 was detected and determined by Agar immundiffusion
and Neutralization test. The results of Wstern blotting assay and intracellular analysis revealed that pUL55 was
expressed most abundantly during the late phase of replication and mainly distributed in cytoplasm in duck
enteritis virus infected cells.
Conclusions: In this study, the duck enteritis virus UL55 protein was successfully expressed in prokaryotic
expression system. Besides, we have prepared the polyclonal antibody against recombinant prtein UL55, and
characterized some properties of the duck enteritis virus UL55 protein for the first time. The research will be useful
for further functional analysis of this gene.
Background
Duck enteritis virus (DEV), alternatively known as Duck
plague virus (DPV), is a fatal pathogen of the family Anati-
dae of the order anseriformes [1], leading to an acute, feb-
rile, contagious, and septic disease to waterfowls of all
ages. The resulting disease designated as duck virus enteri-
tis (DVE) has caused serious losses in commercial duck
production in domestic and wild waterfowl since it was
firstly discovered in Netherlands [2]. To our knowledge,
DEV has been clustered to the subfamily of alphaherpes-
virinae according to the report of the Eighth International
Committee on Taxonomy of Viruses (ICTV) [3]. However,
it has not been classified to any genus yet.
T h eg e n o m eo fD E Vi sc o m p o s e do fal i n e a r ,d o u b l e
stranded DNA. In recent years, due to the advent of
molecular biology and advancements in research related
to it, a lot of DEV genes has been identified, such as US2
to US5 and US10 genes [4,5], UL6 and UL7 genes [6],
UL10 [7], UL24, TK and gH genes [8], UL27 [9], UL31
[10], UL35 [11], UL38 [12], UL45 to UL47 [13-15], UL51
[16], gK [17], gC [18], gE [19], gI [20] and so on. Even so,
a great deal of unkown DEV genes remain to be clarified
to facilitate the investigation of this virus. DEV UL55
gene [GenBank:EU071034] was a kind of that gene whose
properties and functions has not been elucidated yet
since it was identified in our laboratory in 2006 [21]. To
our best knowledge, the UL55 gene of alphaherpesviridae
was supposed to be a late gene. Reports about HSV-2
UL55 protein revealed that the product of HSV-2 UL55
gene may play an accessory role in virion assembly or
maturation [22], but the corresponding homologue gene
of EHV-1 was supposed to mediate persistent infection
[23]. However, the characterization of the DEV UL55
protein (pUL55) remains unclear.
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amplified the DEV UL55 gene by PCR and constructed
a recombinant plamid pET32a(+)/UL55 for prokaryotic
expression. The expression of recombinant pUL55 was
induced by the addition of isopropyl-b-D-thiogalactopyr-
anoside (IPTG) and supposed to be maximum after
optimization. Polyclonal antibody was prepared by
immune rabbits with purified pUL55, and then detected
by agar immunodiffusion and viral neutralization test. It
was subsequently used to determine the expression and
subcellular localization of pUL55 in DEV infected cells.
This work was supposed to facilitate the understanding
of DEV pUL55 and its functional location in infected
cells.
Methods
Computer analysis of DEV pUL55
A complete ORF of DEV CHv strain was first identified in
our laboratory [21] and designated as UL55 gene. It was
about 561 bp and expected to encode a protein compris-
ing 186 amino acids with a putative molecular mass of
20.7981 KDa. A series of bioinformatics aided tools were
used to analyze the intracelluar location of pUL55 :
PSORT II Prediction(from the website http://psort.nibb.ac.
jp/form2.html) [24], TargetP 1.1 (from the website http://
www.cbs.dtu.dk/services/TargetP/) [25], SignalP 3.0(from
the website http://www.cbs.dtu.dk/services/SignalP) [26],
TMHMM 2.0 server (from the website http://www.cbs.
dtu.dk/services/) [27], PredictNLS server(from the website
http://www.rostlab.org/services/predictNLS/) [28], CSS-
Palm 2.0 online server (from the website http://csspalm.
biocuckoo.org/online.php) [29], and the Golgi predictor
(from the website http://ccb.imb.uq.edu.au/golgi/golgi_
predictor.shtml) [30]. Prediction of them were based on
the putative amino acid sequence of pUL55.
Cells, viruses, serums, and vectors
Duck embryo fibroblasts (DEF) were cultured in modified
eagle’s medium (MEM)(Gibco-BRL) supplemented with
10% fetal bovine serum (FBS)(Gibco-BRL), 100 U/ml
penicillin, and 100 μg/ml streptomycin at 37°C. MEM
medium supplemented with 2-3% FBS was used for virus
infection [31]. DEV CHv strain and rabbit anti-DEV
serum were obtained from Key Laboratory of Animal
Disease and Human Health of Sichuan Province [32,33].
Besides, Escherichia coli strain DH5a,E s c h e r i c h i ac o l i
BL21 (DE3) and expression vector pET-32a(+) were pre-
served in our laboratory.
Expression and purification of recombinant UL55 protein
The amplified DEV UL55 gene was directionally cloned
to pMD18T as previously discribed [34]. After confirma-
tion by sequencing, the digested gene fragment of the
recombinant plasmid pMD18-T/UL55 (retrieving by
TIANgel Midi purification Kit) was directionally ligated
into the previously BamH I/Xho I-digested expression
vector pET32a(+), gernerating a recombinant plasmid
pET32a(+)/UL55. Subsequently, the PCR, restriction
enzyme digestion and DNA sequencing (TaKaRa) tests
were performed to ensure the correct insertion. After
that, the positive recombinant plasmids were trans-
formed to Escherichia coli BL21 (DE3) for expression by
the addition of isopropyl-b-D-thiogalactopyranoside
(IPTG). The tempreture and duration of IPTG and its
working concentration were o p t i m i z e da sd e s c r i e dt o
maximize the expression of pUL55 [10]. Cells were cen-
trifugated and lysed in 5×sample buffer (0.1 M Tris-
HCl, 4% SDS, 0.2% bromophenol blue, 20% glycerol,
and 0.1 M DTT, pH 6.8), then analyzed by SDS-PAGE.
The uninduced control culture and the vector control
culture were analyzed in parallel.
The recombinant pUL55 was purified under denaturing
condition by repeated washing [35]. The induced cells
were centrifugated at 10,000 rpm/min for 10 min, and
resuspended in 20 mM Tris buffer (pH 8.0) with the
addition of 0.1 mg/ml lysozyme (0.1 mg/ml) at -20°C
overnight. The cell lysate was then sonicated on ice for 5
m i na ta na m p l i t u d eo f3 0 %w i t ha3 0sp u l s ef r e q u e n c y .
After 10 min centrifugation at 10,000 rpm/min, the
supernatant (soluble fraction) and pellets (insoluble frac-
tion) of it were collected respectively for SDS-PAGE ana-
lysis. Result demonstrated that the recombinant pUL55
has formed inclusion bodies (IB). The pellets were resus-
pended in 20 ml washing buffer (2 M urea, 50 mM Tris-
HCl buffer, 1 mM EDTA, 150 mM NaCl and 0.1% Triton
X-100, pH 8.0) under constant stirring for 10 min, then
followed by centrifugation at 10,000 rpm/min for 10 min
at 4°C. The above steps were repeated five times to
release the trapped protein. The suspension was finally
centrifuged at 10,000 rpm/min for 10 min at 4°C, and
resuspended in denaturing buffer containing 8 M urea,
10 mM PBS, 50 mM Tris-HCl, 50 mM NaCl, 10% glycer-
ine, pH 8.0. The purity of pUL55 was tested by SDS-
PAGE.
Western blotting assays [12]
Western blotting assay was performed using the purified
rabbit anti-DEV (diluted 1:200) IgG to characterize the
reactivity and specificity of the recombinant pUL55. The
purified recombinant pUL55 were separated by 12%
SDS-PAGE and transferred onto polyvinylidene fluoride
(PVDF) membrane at 120 V for 1.5 h in a BioRad mini
Trans-Blot electrophoretic transfer cell (BioRad, Shang-
hai, China). Blocking the membrane with 10% skimmed
milk in TBST (Tris-buffered saline with 0.1% Tween-20,
pH 8.0) for 1 h at 37°C or overnight at 4°C. Sequently,
the membrane was incubated with appropriate dilution
of rabbit anti-DEV (diluted 1:200) serum for 1 h at 4°C
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gated goat anti-rabbit IgG (diluted 1:3000) was added
for incubation. Pre-serum came from non-immune
healthy rabbit blood was disposed parallelly for control.
One hour later, washing the membrane with TBST as
before, followed by 3 min for color development with
substrate solution (DAB 3’3’-Diaminobenzidine tetrahy-
drochloride peroxidase) at 37°C. The reaction was termi-
nated by thoroughly washing with distilled water.
Preparation of polyclonal antibody against recombinant
pUL55
Renaturation of recombinant pUL55 was carreied out by
dilution method and gradient dialysis [31]. Firstly, the
refolding buffer (1 mM EDTA, 0.15 M NaCl, 50 mM
T r i s - H C l ,1m MG S S G ,1m MG S Ha n d1 %A r g i n i n e ,
pH 8.0) was added to the denatured pUL55 slowly until
the urea concentration reached 6 M. Sequently, the
partly refolded protein was dialyzed in different concen-
trations of urea buffer solution (6 M, 4 M, 3 M, 2 M)
containing 50 mM Tris-HCl, 50 mM NaCl, 0.5 mM
EDTA and 10% glycerine, pH 8.0 at 4°C. Changing
the dialyzate of each at least three times a day. At last,
the aggregation was removed by centrifugation and the
supernatant was collected as soluble refolded protein.
For preparation of polyclonal antibodies [31], male
New Zealand white rabbits were first immunized intra-
dermally with a mixture of 0.5 mg renatured recombi-
nant pUL55 and an equal amount of complete Freund’s
adjuvant (Sigma, Shanghai, China). Two weeks later,
0.75 mg purified fusion pUL55 and an equal amount of
Freund’s incomplete adjuvant were used for secondary
immunity. After that, the rabbits were boosted subcuta-
neously with 1.0 mg each of recombinant pUL55 and an
equal amount of incomplete Freund’sa d j u v a n ta ta
1-week interval. Seven days later, the rabbits were
injected intravenously with 0.1 mg purified pUL55 each.
At last, serums were collected 17 days later. Control pre-
immune serum was obtained from the non-vaccinated
healthy rabbits.
The obtained rabbit polyclonal anti-serum against
pUL55 was subsequently purified by ammonium sulfate
precipitation and High-Q anion-exchange chromatogra-
phy [36] following the manufacturer’si n s t r u c t i o n s .T h e
purified IgG fraction was analyzed by 12% SDS-PAGE.
Agar diffusion reaction
Agar diffusion reaction was used to detect the reactivity
and specificity of the purified UL55 anti-serum [37].
One gram of agar was dissolved in 100 ml normal saline
for the test. It was heated, cooled down to 55°C, and
then poured into the plates to a thickness of 2 mm.
After subsequent solidification with cooling, the agar
was perforated with 3 mm diameter holes that may hold
approximately 100 μl of solution. Twenty microliters
each of the pre-immune serum, 1:2, 1:4, 1:8, 1:16 and
1:32 diluted anti-serum was added into the peripheral
apertures. At last, 20 μl purified pUL55 was added into
the central aperture. The plate was incubated at 37°C
for 24 h before observation.
Viral neutralization test
Viral neutralization test was used to determine the neu-
tralizing viral antibody titer of the obtained anti-serum.
DEFs were prepared as we described above, and 350 μlo f
cell suspension was added to each well of the 48-well
plate for incubation. Sequently, inactivated anti-pUL55
serums (56°C for 30 min) were serially diluted twofold
from 1:1 to 1:32. Mixing 25 μlo ft h e2 0 0T C I D 5 0
(TCID50 = 10
-6.334) virus which was diluted from the
virus stock suspension previously with an equal volume
o fs e r u md i l u t i o n ,a n di n c u b a t i n gi ta t3 7 ° Cf o r1h .
When the cells grew into a monolayer, 50 μl of each
incubated antiserum was inoculated onto the cells for
infection. Meanwhile, seven contrast controls were set up
for later observation: blank control 1:2, diluted anti-
serum, 200 TCID50, 100 TCID50, 10 TCID50, 1 TCID50
and 0.1 TCID50 was respectively added to the cell cul-
ture. Each dilution of these invovled serums and viruses
were tested in triplicate. After 1 h adsorption at 37°C, the
cells were overlaid with the MEM maintenance media for
incubation. Observation the cytopathic effect (CPE) of
them timely.
The dynamic expression of UL55 protein in DEV-infected
cells
DEFs infected and mock infected with DEV were har-
v e s t e da t8h ,1 2h ,2 4h ,3 6h ,4 8h ,6 0ha n d7 2h
post-infection to determine the kinetics of pUL55
expression. Cells lysate were mixed with 5×SDS sample
buffer and heated at 100°C for 10 min. Then centrifuga-
lization it before SDS-PAGE. After gel separation, pro-
teins were transformed onto PVDF membrane for
western blotting. It’s worth noting that, here purified
DEV UL55 IgG (diluted 1:64) substitued DEV IgG for
dynamic expession analysis.
Intracellular localization of UL55 protein in DEV-infected
cells
Indrect immunofluorescent microscopy was used to
investigate the intracellular location of pUL55 in
infected cells [25]. Preparing monolayers of DEFs as a
matter of routine, cells were expected to grow on cover-
slips in six-well plates and they were supposed to be
mock infected or infected with DEV. At different times
(5.5 h, 11 h, 16 h, 22.5 h, 30 h, 35 h, 40 h, 45.5 h, 49 h,
54 h, 60 h, 70 h and 74 h post infection), cells were har-
vested and fixed with 4% paraformaldehyde overnight at
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Page 3 of 154°C. Sequently, they were washed with PBS buffer and
permeabilized with 0.1% Triton X-100 for 30 min. After
that, washing the cells with PBS contaning 0.1% tween-
2 0f o rt h r e et i m e sb e f o r et h e yw e r eb l o c k e dw i t hP B S
containing 4% BSA for at least 1 h at 37°C. Then, the
cells were incubated overnight with purified UL55 IgG
(1:64 diluted) in PBS containing 1% BSA at 4°C. Three
times washing had been performed as decribed above
before they were treated with 1:100 diluted FITC conju-
gated goat anti-rabbit IgG (Sino American Biotechnol-
ogy Co.) at 37°C for 1 h. The cell nuclei were visualized
by 4’, 6-diamidino-2-phenylindole (DAPI) counter-stain-
ing (5.0 μg/ml, Beyotime Institute of Biotechnology,
Shanghai, China) after washing three times. The images
were captured with fluorescence microscopy (Nikon,
Japan) [25].
Results
Prediction of subcellular localization of DEV pUL55
Computer analysis of the subcellular localization of DEV
pUL55 suggested that the pUL55 was mainly located in
cytoplasmic (60.9%) of infected cells, then in cytoskeletal
(17.4%), nuclear (13.0%), peroxisomal (4.3%) and mito-
chondria (4.3%) sequentially. However, according to the
prediction, DEV pUL55 contained no potential mito-
chondrial targeting peptide, N-terminal signal peptides,
transmembrane region and nuclear localization signal
(NLS). Further, Golgi prediction results indicated pUL55
was not a Golgi type II membrane protein(Golgi loca-
lised transmembrane protein) since the index values of a
Golgi protein should be geater than the threshold
(20.005) while the index values of pUL55 was 0.
Expression and purification of UL55 recombinant protein
Recombinant plasmids containing the encoding region
of DEV UL55 were constructed for expression. Sche-
matic diagrams of the cloning strategy of DEV UL55
were shown in Figure 1. The constructed recombinant
plasmids pET32a(+)/UL55 was transformed into E. coli
BL21 (DE3) for expression. After incubation at 37°C, the
cultures were analyzed by SDS-PAGE. Results demon-
strated that the E. coli BL21 (DE3) transformed with
recombinant plasmid pET32a(+)/UL55 expressed a con-
siderable amounts of a 40 KDa protein and it was
mainly in the insoluble fraction(Figure 2, Lane 5). How-
ever, the corresponding band of pUL55 was absent in
the inducing culture of pET32a(+) vector (Figure 2,
Lane 1), the cultures of pET-32a(+)/UL55 before
Figure 1 The cloning strategy for constructing the UL55 recombinant plasmids. A. Schematic diagram of the UL55 ORF cloned into the
pMD18-T cloning vector. B. Construction of the recombinant expression plasmid pET-32a(+)/UL55.
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Page 4 of 15induction (Figure 2, Lane 2-3), and the supernatant of
the culture of pET-32a(+)/UL55 after induction (Figure
2, Lane 4). Figure 3 indicated the optimal expression
conditions of pUL55 in E. coli BL21 containing the
working concentration of IPTG for inducing, the induc-
tion tempreture and the duration of IPTG. As a result,
the maximum expression of pUL55 in prokaryotic sys-
tem was induced by 0.2 mM IPTG (Figure 3A, Lane 5)
at 37°C (Figure 3B, Lane 2) for 4.0 h (Figure 3C, Lane
1).
Purification of DEV pUL55 was performed under
denaturing condition since Figure 2 has demonstrated
most of the pUL55 were expressed as insoluble inclu-
sion bodies (IB) in E. coli. Eluant containing 2 M urea
was used for purification. After washing five times, the
purified pUL55 was dissolved finally in 8 M urea. SDS-
PAGE analysis demonstrated the purity of pUL55 after
washing (Figure 4, Lane 2) was higher compared to the
crude pUL55 (Figure 4, Lane 1). Immunogenicity of the
purified pUL55 was detected by Western blotting assay.
As shown in Figure 5, the DEV anti-serum can specifi-
cally recognized a 40 KDa band (Figure 5, Lane 2),
which corresponded to the theoretical molecular mass
of pET32a(+)/UL55. However, no positive signal was
observed when using the pre-immune serum in western
blotting (Figure 5, Lane 1).
Purified pUL55 was supposed to be refolded by dilu-
tion method and gradient dialysis. SDS-PAGE was per-
formed to analysis the renatured pUL55 (Figure 6A,
Lane 1) firstly. Then anti-DEV serum was used to recog-
nize the renatured pUL55. Band about 40 KDa repre-
sented pUL55 was observed by Western-blotting assay
Figure 2 The expression pET32a(+)/UL55 protein produced in
E. coli strain BL21 (DE3). The pET32a(+)/UL55 protein was
expressed in E. coli BL21(DE3) host strains. M represented standard
protein molecular weight markers. Lane 1, the culture of pET-32a(+)
after induction in E.coli BL21; Lane 2 and Lane3, the supernatant
and pellet of the recombinant pET-32a(+)/UL55 cultures before
induction in E.coli BL21, respectively. Lane 4 and Lane 5, the
supernatant and pellet of the recombinant pET-32a(+)/UL55 cultures
after induction in E.coli BL21, respectively.
Figure 3 The optimal expression condition of pET32a(+)/UL55 protein. A. The determination of the optimal final concentration of IPTG.
Lanes 1, 2, 3, 4, 5 and 6 represented the final concentrations of IPTG were 1.0 mM, 0.8 mM, 0.6 mM, 0.4 mM, 0.2 mM and 0.1 mM respectively.
B. The determination of the optimal induced temperature. Lanes 1, 2 and 3 represented the induction temperatures were 30°C, 37°C and 25°C,
respectively. C. The determination of the optimal duration of IPTG. Lanes 1, 2, 3, 4 and 5 represented the durations of IPTG were 4.0 h, 5.0 h, 6.0
h, 7.0 h and 8.0 h, respectively.
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Page 5 of 15(Figure 6B, Lane 2), indicating that the renatured pUL55
reacted with anti-DEV serum. Corresponding band was
absent when recognized by pre-immune serum (Figure
6B, Lane1).
Verification the character of polyclonal antibody against
DEV pUL55
Polyclonal antibodies against DEV pUL55 obtained from
immune rabbits were purified before using. SDS-PAGE
analysis described the purification result of anti-pUL55
serum (Figure 7A, Lane 2) by comparison. The reactivity
and specificity of it was detected by Western blotting
assay. As shown in Figure 7B, the purified anti-pUL55
serum reacted strongly with an approximate 40 KDa pro-
tein which represented renatured DEV pUL55 (Figure 7B,
Lane 1). However, the corresponding band was not found
when using pre-immune serum (Figure 7B, Lane 2).
Agar diffusion reaction was performed to determine
the immunoreactivity of anti-pUL55 serum with purified
pUL55. Figure 8 suggested the highest titer of the agar
diffusion reaction of anti-pUL55 serum with pUL55 was
1:16 (Figure 8, lable 4). Pre-immune serum used as a
negative control didn’t show any antigen-antibody com-
plexes (Figure 8, lable 6).
Observation of the neutralization titer of the rabbit
anti-pUL55 polyclonal antibody was detected by micro
neutralization test. Calcutating 50% serum neutralized
through Reed-muench method [38]. As a result, the
neutralization titer of the rabbit anti-UL55 polyclonal
antibody was 1:7.484 (data not shown).
Dynamic expression of pUL55 in DEV-infected cells
DEFs mock-infected or infected with DEV were ana-
lyzed by western blotting assays at a series of time post
infecion for the purpose of monitoring the dynamic
Figure 4 Purification of pET32a(+)/UL55 IB. SDS-PAGE analysis of
the purity of recombinant pUL55. M represented standard protein
molecular weight markers. Lane 1, the pellet of expressed pUL55
after induction in E.coli BL21; Lane 2, the expressed pUL55 was
purified by washing five times.
Figure 5 The immunoreactivity of the recombinant UL55
protein. The immunoreactivity of the recombinant UL55 protein
was analyzed by western blotting assay with the rabbit anti-DEV
IgG. M: Prestained Protein Molecular Weight marker; Lane 1, the
purified pUL55 was analyzed with pre-serum. Lane 2, the purified
pUL55 was analyzed with the rabbit anti-DEV monoclonal antibody.
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Page 6 of 15expression of pUL55. Cells were harvested at different
time, and separated by SDS-PAGE. Then, proteins were
electrophoretically transferred onto PVDF membrane
for Western blotting analysis using anti-pUL55 serum.
Result in Figure 9 revealed that the DEV pUL55 was
easily detected as early as 8 h p.i (Figure 9, Lane 1) and
seemed to keep increasing until maximum at 24 h p.i
(Figure 9, Lane 3), after that, a visble band was present
at decreased levels untile 60 h p.i (Figure 9, Lane 1).
Intracellular localization and distribution of DEV pUL55 in
DEV-infected cells
The intracellular distribution of pUL55 in DEV infected
cells was examined by indirect immunofluorescence
staining with purified anti-pUL55 serum. At various
times after infection, DEF cells were collected and fixed
in cold paraformaldehyde. Optimization results revealed
the coverslips were expected to be fixed at 4°C overnight
Figure 6 Identification of the renatured pET32a(+)/UL55
protein. The renaturation of pUL55 was detected by SDS-PAGE and
Western blotting assay using anti-DEV serum for recognization. A.M :
Molecular mass marker; Lane 1, the renatured pUL55; Lane 2, the
recombinant pUL55 without purification and renaturation. B.M :
Prestained Protein Molecular Weight Marker; Lane 1, identified the
renatured pUL55 with pre-serum; Lane 2, identified the the
renatured pUL55 with the rabbit anti-DEV IgG.
Figure 7 Verification the character of the UL55 polyclonal
antibody. A. SDS-PAGE analysis of the anti-pUL55 serum and
purified anti-pUL55 serum. M: Molecular mass marker; Lane 1, The
IgG proteins of UL55 antiserum examined by SDS-PAGE; Lane 2, The
purified IgG of pUL55 examined by SDS-PAGE. H and L indicated
the position of heavy and light chains of the IgG proteins,
respectively. B. The renatured pUL55 was recognized by purified
anti-pUL55 serum. M: Prestained Protein Molecular Weight Marker;
Lane 1, the renaturated UL55 protein was analyzed with purified
anti-pUL55 IgG; Lane 2, the renaturated UL55 protein was
recognized by pre-serum.
Figure 8 Agar diffusion reaction.A g a rd i f f u s i o nr e a c t i o nw a s
designed for dectecting specificity and sensitivity of anti-pUL55
serum. The result of agar diffusion reaction of the anti-pUL55 serum
with purified pUL55 suggested the largest dilution multiple of it
was 1:16. 1-5, represented 1:2, 1:4, 1:8, 1:16 and 1:32 diluted anti-
seraum, respectively; 6, rabbit pre-immune serum; 7, Purified pUL55.
Figure 9 Dynamic expression of UL55 in DEV-infected cells. The
kinetics of pUL55 was examined by SDS-PAGE and Western blotting
assay. M: Prestained Protein Molecular Weight Marker; Lane 1-7,
DEFs infected with DEV were harvested at 8 h, 12 h, 24 h, 36 h, 48
h, 60 h and 72 h post-infection. The lysates of DEV-infected was
analyzed by rabbit anti-pUL55 serum. Lane 8, DEFs mock infected
with DEV were done in parallel.
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Page 7 of 15with 4% cold paraformaldehyde, and then treated with 4%
BSA to block the nonspecific staining, the permeabiliza-
tion time was with 0.2% (v/v) TrionX-100 in PBS for an
additional 30 min at 4°C and the anti-pUL55 IgG was
supposed to diluted 1:64 to incubate at 4°C overnight in
t h ec o v e r s l i p s( d a t a sn o ts h o w n ) .A ss h o w ni nF i g u r e
10C, the pUL55 was distributed in bright fluorescent
granules in the cytoplasm of infected cells at 5.5 h p.i.
However, these fluorescence pellets were absent from
mock-infected cells (Figure 10A), and no significant
fluorescence was observed with the preimmune serum
(Figure 10B). After that, the detectable fluoresecence
structures kept increasing, the strongest fluorescence was
observed at 22.5 h p.i (Figure 11F). From Figure 10C to
Figure 12H, we easily found the bringht fluorescence
granules were widely distributed in the cytoplasm and
gradually near the periphery of the nucleus even traces of
them within nuclear. Starting from 40 h p.i, the fluores-
cence granules expressed diffusely throughuout the cyto-
p l a s mt h e nr e c l u s t e r e dt ob r i g h ts p e c k l e ds t r u c t u r e s
which distributed especially in the juxtanuclear region
(from Figure 13J to Figure 14M). These fluorescence
Figure 10 Intracellular localization of DEV pUL55 in mock-infected cells and DEV-infected cells at 5.5 h post-infection. A. Mock-infected
cells were fixed; B-C. DEV-infected cells were fixed at 5.5 h post-infection; The sample B was incubated with rabbit pre-immune serum while
samples A and C were incubated with anti-pUL55 serum and subsequently stained with fluorescein isothiocyanate(FITC)-conjugated secondary
antibody. Nuclei were counterstained with DAPI(blue). The merged fluorescence microscopy image of DEF are shown in panels A-C with high
magnification (600×).
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Page 8 of 15gradually diminished as time going on. Meanwhile, the
DEF cells turned into the round shape and began to shed
off at 54 h p.i. At 74 h post infection (Figure 14O), the
pUL55-specific fluorescence almost vanish following the
cytoplasm disintegration in infected cells.
Discussion
The product of DEV UL55 gene which has been desig-
nated as pUL55, was a 186 amino acids protein encoded
by a 561 bp ORF [26]. In our research, a series of
experiments were preformed to characterize the duck
enteritis virus UL55 protein. As the first step towards
studying the characterization of the DEV pUL55, the
digested UL55 fragment was directionally inserted into
the pMD18-T and pET32a(+) vector sequentially to
constrcut recombinant plasmids (Figure 1). PCR,
Restriction enzyme digestion and DNA sequencing were
used to comfirm the correctness of insertion as
described previously [34]. The determined recombinant
plasmid pET32a(+)/UL55 was transformed into Escheri-
chia coli BL21 for prokaryotic expression. The optimal
expression condition of recombinant pUL55 was
Figure 11 Intracellular localization of DEV pUL55 in DEV-infected cells at 11 h, 16 h, 22.5 h post-infection. D-F. DEV-infected cells were
fixed at 11 h, 16 h, 22.5 h post-infection. Samples were incubated with anti-pUL55 serum and subsequently stained with fluorescein
isothiocyanate(FITC)-conjugated secondary antibody. Nuclei were counterstained with DAPI(blue). The merged fluorescence microscopy image of
DEF are shown in panels D-F with high magnification (600×).
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Page 9 of 15induced by 0.2 mM IPTG at 37°C for 4 h. A 6×His-Tag
fusion pUL55 approximately 40 KDa was collected as
inclusion bodies in exprssion procedure and can be
easily purified after washing five times under denaturing
conditions. The refolded pUL55 could be recognized by
rabbit anti-DEV IgG through western blotting assay
which suggested a good immunogenicity of pUL55.
Dilution method and gradient dialysis were used to
restore the natural structure of denatured pUL55. SDS-
PAGE and western blotting analysis indicated that the
renatured pUL55 obtained higher purity and immuno-
genicity which was more suitable for producing specific
polyclonal antiserum of pUL55.
The obtained rabbit polyclonal UL55 IgG in our
work was purified using ammonium sulfate precipita-
tion and High-Q anion-exchange chromatography.
SDS-PAGE analysis of the extractive anti-pUL55 IgG
detected two expected bands about 55 KDa and 25
KDa respectively. The refolded pUL55 was used to
recognize the extractive anti-pUL55 IgG by western
Figure 12 Intracellular localization of DEV pUL55 in DEV-infected cells at 30 h, 35 h, 40 h post-infection. G-I. DEV-infected cells were
fixed at 30 h, 35 h, 40 h post-infection. Samples were incubated with anti-pUL55 serum and subsequently stained with fluorescein
isothiocyanate(FITC)-conjugated secondary antibody. Nuclei were counterstained with DAPI(blue). The merged fluorescence microscopy image of
DEF are shown in panels G-I with high magnification (600×).
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Page 10 of 15blotting assay. These results indicated that the rena-
tured pUL55 has induced a strong immunological
response and the prepared antiserum had a high level
of specificity. It can be widely used for identification
features of DEV UL55 gene product. The titer of agar
diffusion reaction reached 1:16 which suggested the
extractive anti-pUL55 IgG was specific and sensitive to
pUL55. Moreover, the determined titers of Viral neu-
tralization test demonstrated that pUL55 can neutra-
lized DEV and anti-DEV infection, also has the
potential to produce subunit vaccines [39].
Kinetics of UL55 expression in DEV infected DEFs
was determined by western blotting. Results suggested
the DEV pUL55 became detectable as early as 8 h p.i,
increased in amount and reached it highest level at 24 h
p.i. No appreciable protein was detected until 60 h p.i.
The DEV UL55 protein existed in infedcted cells almost
throughout the viral replication cycle. In the temporally
regulated cascade of herpesvirus gene expression, the
products of herpesvirus genes has been divided into
three types according to the transcription conditions of
HSV-1, PRV [40], HCMV [41]. Proteins encoded by
Figure 13 Intracellular localization of DEV pUL55 in DEV-infected cells at 5.5 h, 49 h, 54 h post-infection. J-L. DEV-infected cells were
fixed at 45.5 h, 49 h, 54 h post-infection. Samples were incubated with anti-pUL55 serum and subsequently stained with fluorescein
isothiocyanate(FITC)-conjugated secondary antibody. Nuclei were counterstained with DAPI(blue). The merged fluorescence microscopy image of
DEF are shown in panels J-L with high magnification (600×).
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Page 11 of 15immediate-early (IE) and early (E) genes were supposed
to be expressed firstly which might be involved in virus
replication. The following expressed proteins were struc-
tual proteins of virus encoded late(L) genes which were
further subdivided into two categories as leaky-late (g1)
or strict-late (g2) [18]. The last kind of proteins were
some nonessential proteins encoded by optional genes.
To our knowledge, the protein kinase pUS3 [42] and
dUT-Pase [43] wich were first detected at 2 h.p.i. and 4
h p.i. respectively has been defined as immediate-early
products. By contrast, the pUL31 [10] and pUL51 [25]
of DEV were classified to late gene products since they
were first detected at 6 h.p.i. and 8 h.p.i, respectively.
Consequently, the pUL55 was concluded to be the pro-
d u c to fal a t eg e n ea n dm i g h tb eac o m p o n e n to fD E V
virions. Researches about HSV-2 UL55 gene product in
infected cells suggestted the pUL55 protein was synthe-
sized as a g2 gene but not a stable component of HSV-2
virions [22].
Viruses use the host synthetic machinery for replication.
Viral proteins need to be targeted to the appropriate intra-
cellular compartments of the host cell to fulfill their roles
Figure 14 Intracellular localization of DEV pUL55 in DEV-infected cells at 60 h, 70 h and 74 h post-infection. M-O. DEV-infected cells
were fixed at 60 h, 70 h and 74 h post-infection. Samples were incubated with anti-pUL55 serum and subsequently stained with fluorescein
isothiocyanate(FITC)-conjugated secondary antibody. Nuclei were counterstained with DAPI(blue). The merged fluorescence microscopy image of
DEF are shown in panels M-O with high magnification (600×).
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Page 12 of 15[25]. Regional distribution of protein in cells will influence
the procedures of protein folding, polymn and post-tran-
scriptional modification. Then further affect the fuctions
of cell [44]. Only if the synthetic protein be transformed
into specific organelle did the vital movements working
orderly. Any deviation of location will have significant
impacts on functions even the vital movement of cells.
Proteins which merely located in nucleus are expected to
participate the metabolic processes of DNA or RNA in
cells. Otherwise, the proteins distributed in cytoplasm or
cytolemma have nothing to do with the above procedures.
Study the intracellular location of proteins will increase
our understanding of the role of these proteins in host
cells and could also be useful for the design of improved
therapeutic interventions.
Previously research indicated that the indirect immu-
nofluorescence experiments was a useful method for
subcellular location of protein in infected cells [25]. In
fact, it is a specific, sensitive and rapid antigen-antibody
binding reaction. In our research, we found the location
of DEV pUL55 in infected cells was dynamic changes
during the life cycle of DEFs. That probably means the
pUL55 has an important realationship with the propaga-
tion of DEV in DEFs. Results in Figure 10 to Figure 14
suggested the pUL55 was predominantly located in cyto-
plasm as the computational analysis predicted (60.9%
into cytoplasmic), and small amount of it within nuclear.
It started to expression in cytoplasm as early as 5.5 h p.i,
then diffusion to cytoplasm and gradually distributed
near the periphery of the nucleus between 11 h p.i and
35 h p.i. After that, the fluorescence granules clustered
to speckled structures and distributed dominantly in the
juxtanuclear region from 40 h p.i. At last, the fluores-
cence diminished since 54 h p.i that suggested the intra-
celluar location variation of pUL55 might due to the
place transformation of protein synthesis and its func-
tion exertion. It was presumed that the pUL55 might be
synthesized in cytoplasm initially then transformed
nearby the periphery of the nucleus to implement its
biologic functions. According to previous report, HSV-2
UL55 was located within and near the periphery of
nucleus and abutted on and partially overlapped the
capsid protein ICP35 which would coalesced VP5,
VP19c at late times p.i and located at the periphery of
large globular structures composed of proteins involved
in DNA replication [22]. Thus, the pUL55 located
nearby the perinucler space to pariticipate in the pack-
age of virus. When packaged viurs DNA which has been
wrappered by ICP35 and its neucleocapsid aggregates
transformed nearby [45], the synthesized pUL55 com-
bined to it as a tegument component [46] or something.
However, it might participate in package through some
unkown mechanism instead of to be a component.
Besides, the distribution of fluorescence transformed
once again go along with the variation of DEV viron in
infected cells since 35 h p.i can be explained to be
related to the propagation of virus in DEFs and cyto-
pathic mechanism. The fuloresence structures gradually
diminished to shed off afterwards probably due to the
maturity, egress and release of viurs according to the
acceptable propagation pattern of DEV in host cells
[47]. Apart from that, pUL55 became undetectable
probably because it is a low abandance protein in pack-
aged virons [46] or it is not a stable component of DEV
virions [22]. Of course, the above assumptions about
pUL55 and its mechanism of involving in DEV propaga-
tion need to be determined in future studies.
Electron microscopic characterization of duck plague
virus [48] suggested the initial progeny virus nuecleocap-
sids are detectable since 12 h p.i and the mature virus
was observed at 24 h p.i. The initial 6 h are latency period
of DEV [49]. In our research, pUL55 was firstly detected
at 5.5 h p.i which was probably produced by parental
viruses since pUL55 has been designated to be a late
gene according to previrously report [22] and dynamic
expression of pUL55 we had investigated above. The
fluorescence granules repesented pUL55 were clusterd to
peak at 22.5 h p.i corresponding to the mature time of
DEV and the dynamic distribution of pUL55 in cells at
24 h p.i basically. After that, fluorescence became weak
gradually due to the release of mature DEV.
Conclusions
In this work, the recombinant plasmid pET32a(+)/UL55
was constructed successfully for expression in prokaryo-
tic system. The purified and renatured recombinant
pUL55, which was recognized well with anti-DEV
serum, was used for preparation of specific anti-pUL55
serum. Viral neutralization test demonstrated that the
pUL55 has the potential to produce subunit vaccines,
and possesses the functions of neutralizing DEV and
anti-DEV infection. The determined anti-pUL55 serum
was used for characterization of pUL55 by Western
blotting assay and indrect immunofluorescence. As a
result, we found the expression of this gene appeared at
the late stage of infection in infected DEFs and pUL55
was predominantly located in cytoplasm and traces of it
in nuclear. pUL55 participated the assembly and
maturation procedures of virus in some uncertain way.
Characterization of pUL55 gave some insights of this
gene and DEV investigation. However, further
researches about this gene are expected to give more
evidence in future.
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